GPCR
Price
$74.58
Change
-$6.68 (-8.22%)
Updated
Feb 5, 03:01 PM (EDT)
Capitalization
5.74B
49 days until earnings call
Intraday BUY SELL Signals
KRYS
Price
$271.27
Change
+$2.14 (+0.80%)
Updated
Feb 5, 03:17 PM (EDT)
Capitalization
7.81B
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs KRYS

Header iconGPCR vs KRYS Comparison
Open Charts GPCR vs KRYSBanner chart's image
Structure Therapeutics
Price$74.58
Change-$6.68 (-8.22%)
Volume$200
Capitalization5.74B
Krystal Biotech
Price$271.27
Change+$2.14 (+0.80%)
Volume$100
Capitalization7.81B
GPCR vs KRYS Comparison Chart in %
View a ticker or compare two or three
VS
GPCR vs. KRYS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and KRYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GPCR: $81.26 vs. KRYS: $269.13)
Brand notoriety: GPCR and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 59% vs. KRYS: 143%
Market capitalization -- GPCR: $5.74B vs. KRYS: $7.81B
GPCR [@Biotechnology] is valued at $5.74B. KRYS’s [@Biotechnology] market capitalization is $7.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than GPCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 4 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 4 bullish, 4 bearish.
  • KRYS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GPCR and KRYS are a good buy in the short-term.

Price Growth

GPCR (@Biotechnology) experienced а -8.75% price change this week, while KRYS (@Biotechnology) price change was -1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

GPCR is expected to report earnings on Mar 26, 2026.

KRYS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($7.81B) has a higher market cap than GPCR($5.74B). GPCR YTD gains are higher at: 16.837 vs. KRYS (9.163). KRYS has higher annual earnings (EBITDA): 165M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. KRYS (731M). GPCR has less debt than KRYS: GPCR (7.09M) vs KRYS (9.51M). KRYS has higher revenues than GPCR: KRYS (373M) vs GPCR (0).
GPCRKRYSGPCR / KRYS
Capitalization5.74B7.81B74%
EBITDA-246.42M165M-149%
Gain YTD16.8379.163184%
P/E RatioN/A40.36-
Revenue0373M-
Total Cash799M731M109%
Total Debt7.09M9.51M75%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCRKRYS
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
KRYS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPNNX6.220.05
+0.77%
Invesco SteelPath MLP Income R
TEMIX33.690.20
+0.60%
Franklin Mutual International Value A
ZGFIX18.87-0.07
-0.37%
American Beacon Ninety One Gbl Frnchs R5
REEBX62.13-0.37
-0.59%
American Funds EUPAC R2E
MELIX17.43-0.28
-1.58%
Morgan Stanley Inst EMkts Ldrs I

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with ATOS. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-3.01%
ATOS - GPCR
80%
Closely correlated
-4.34%
PHGE - GPCR
77%
Closely correlated
-7.36%
PMN - GPCR
77%
Closely correlated
-1.57%
CANF - GPCR
74%
Closely correlated
-0.25%
ANL - GPCR
73%
Closely correlated
+7.23%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been closely correlated with ERAS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if KRYS jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-3.73%
ERAS - KRYS
71%
Closely correlated
+6.19%
ROIV - KRYS
67%
Closely correlated
-1.46%
ACET - KRYS
67%
Closely correlated
-3.51%
GPCR - KRYS
67%
Closely correlated
-3.01%
GLSI - KRYS
66%
Closely correlated
-3.62%
More